Kwality Pharmaceuticals Ltd (KPL) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of Kwality Pharmaceuticals Ltd stock ₹1,211, price ₹4,195, that is 71.1% below the price, quality 57 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Kwality Pharmaceuticals Ltd
KPL · BSEFar too expensive (fair value 71% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹104.50 – ₹4,195 · fair‑value band ₹848.01 – ₹1,575 · the ₹4,195 price screens above the ₹1,211 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Kwality Pharmaceuticals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally.
Show moreShow less
It offers its products in various dosage forms, including liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments/cream, external preparations, ORS, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized and covid products, syrups, daunorubicin, and other various categories, such as Beta Lactam, non-Beta Lactam, hormones, cytotoxic (oncology), and effervescent.
The company also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.
Stock analysis
Kwality Pharmaceuticals Ltd (KPL) currently trades at ₹4,195, while our model-based Fair Value estimate is ₹1,211, 71% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹1,268 per share, and 0 of the 14 models we run sit above the ₹4,195 price.
Bear case: the Asset-Based group reads lowest at ₹139.80, and 14 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹848.01 (bear) to ₹1,575 (bull), the price of ₹4,195 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Kwality Pharmaceuticals Ltd reported revenue of ₹5.0B in FY2025 versus ₹6.3B in FY2021, a compound −5.3%/yr. Reported net income was ₹673M in FY2025, compounding +26.6%/yr from FY2021.
Key figures
Market cap ₹43.5B (≈ $466M) Small · P/E ratio 53.7 · P/S ratio 7.86 · EPS (TTM) ₹78.10 · Net margin 14.6% · Return on equity 22.7% · Return on assets (EBIT) 6.8% (5-year average) · Operating margin 22.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 71 out of 100 (medium confidence).
What moves the price
The share trades at its 52-week high and 381% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −71%, KPL screens richer than that median.
Fair Value models
All 14 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
KPL screens overvalued: fair value 71% below the price. Compare with Merck KGaA →
Compare Kwality Pharmaceuticals Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 607 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- Stock screener with 62 metrics
- Undervalued stocks: Healthcare
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.48 | $113.53 | +36% | vs KPL |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.90 | ¥52.43 | +12% | vs KPL |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,872 | ₹1,983 | +6% | vs KPL |
| Haleon plc HLN | $9.05 | $8.47 | −6% | vs KPL |
| Merck KGaA MRK | €149.50 | €108.83 | −27% | vs KPL |
| Galderma Group GALD | CHF 187.55 | CHF 112.46 | −40% | vs KPL |
| Takeda Pharmaceutical Company TAK | $21.64 | $11.23 | −48% | vs KPL |
| Sandoz Group SDZ | CHF 81.50 | CHF 40.91 | −50% | vs KPL |
| Teva Pharmaceutical Industries Limited TEVA | $42.62 | $20.74 | −51% | vs KPL |
| Divi's Laboratories Limited DIVISLAB | ₹11,049 | ₹1,567 | −86% | vs KPL |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Kwality Pharmaceuticals Ltd (KPL) overvalued or undervalued?
What is the fair value of KPL?
What is the quality score of KPL?
What is the price target for Kwality Pharmaceuticals Ltd (KPL)?
What is the Kwality Pharmaceuticals Ltd stock forecast for 2026?
What is the revenue of Kwality Pharmaceuticals Ltd (KPL)?
What is the intrinsic value of Kwality Pharmaceuticals Ltd (KPL)?
Is Kwality Pharmaceuticals Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of KPL?
How much is Kwality Pharmaceuticals Ltd worth?
What do the bullish and bearish scenarios say about KPL?
What is the P/E ratio of KPL?
How solid is the balance sheet of Kwality Pharmaceuticals Ltd (KPL)?
How far is KPL from its 52-week high?
Which stocks are comparable to Kwality Pharmaceuticals Ltd?
Is Kwality Pharmaceuticals Ltd stock attractive at the current price?
How is the fair value of KPL calculated?
Is it still worth investing in stocks now?
What is the share price of Kwality Pharmaceuticals Ltd (KPL)?
What should I pay attention to with Kwality Pharmaceuticals Ltd right now?
Key figures of Kwality Pharmaceuticals Ltd
How large is the market capitalisation of Kwality Pharmaceuticals Ltd (KPL)?
What is the P/S ratio of Kwality Pharmaceuticals Ltd (KPL)?
What are the earnings per share of Kwality Pharmaceuticals Ltd (KPL)?
What is the net margin of Kwality Pharmaceuticals Ltd (KPL)?
What is the return on equity of Kwality Pharmaceuticals Ltd (KPL)?
What is the EBIT return on assets of Kwality Pharmaceuticals Ltd (KPL)?
What is the operating margin of Kwality Pharmaceuticals Ltd (KPL)?
How fast is revenue growing at Kwality Pharmaceuticals Ltd (KPL)?
How fast are earnings growing at Kwality Pharmaceuticals Ltd (KPL)?
How much free cash flow does Kwality Pharmaceuticals Ltd (KPL) generate?
How much net debt does Kwality Pharmaceuticals Ltd (KPL) carry?
Watch Kwality Pharmaceuticals Ltd in the live analysis
One click puts Kwality Pharmaceuticals Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.